Skip to main content
null
Clinical Hematology International
  • Menu
  • Articles
    • Case Report
    • Case study
    • Correspondence
    • Editorial
    • General
    • Original Research Articles
    • Perspective Article
    • Research Articles
    • Retrospective study
    • Review Articles
    • Survey
    • Systematic Reviews
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Blog
  • Conference-Event-Webinar
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:44347/feed
General
Vol. 4, Issue 4, 2022August 23, 2022 BST

Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series

Shamis Khan, Sara Taveras Alam, Rosa Torres Ramos, John Etumbani Mbue, Effrosyni Apostolidou, Gustavo A. Rivero, Sarvari Venkata Yellapragada,
Luspatercept
https://doi.org/10.1007/s44228-022-00016-4
Clinical Hematology International
Khan, Shamis, Sara Taveras Alam, Rosa Torres Ramos, John Etumbani Mbue, Effrosyni Apostolidou, Gustavo A. Rivero, and Sarvari Venkata Yellapragada. 2022. “Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series.” Clinical Hematology International 4 (4): 148–51. https:/​/​doi.org/​10.1007/​s44228-022-00016-4.
Save article as...▾

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system